. . . . . . . . . "\"* Medullary Thyroid Carcinoma TANZEUM is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Warnings and Precautions (5.1)] * Hypersensitivity TANZEUM is contraindicated in patients with a prior serious hypersensitivity reaction to albiglutide or to any of the product components. Serious hypersensitivity reactions including angioedema have been reported with TANZEUM [see Warnings and Precautions (5.4)]. * 4 * 4 5.4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "KQHqy6uCB8nZyZdqzZKjDYam5btTuYgWqtSi6lH8sOVam3Fm1ebhPo6RNKAiC4wbVRQxeHUwCzg/Fp2+xMzATtkW0f0KHU6zA5GeZ3HaKdfOwIsRt+CPKrpCPwiUdpLxdn8LLP4mEzMpJFToUTy4W29O/cmd9BgUikZr3MkILM4=" . . "2021-08-25T14:02:45.516+02:00"^^ . . . . .